VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,216,111 | -33.1% | 528,295 | -25.2% | 0.02% | -44.7% |
Q2 2023 | $21,248,007 | +3.9% | 706,133 | +12.7% | 0.04% | 0.0% |
Q1 2023 | $20,454,635 | +10.0% | 626,813 | -3.4% | 0.04% | 0.0% |
Q4 2022 | $18,593,344 | +62.7% | 648,736 | +36.9% | 0.04% | +46.2% |
Q3 2022 | $11,426,000 | -38.4% | 473,740 | -29.9% | 0.03% | -36.6% |
Q2 2022 | $18,551,000 | -22.3% | 675,552 | -3.9% | 0.04% | -10.9% |
Q1 2022 | $23,867,000 | +22.5% | 702,698 | +15.2% | 0.05% | +24.3% |
Q4 2021 | $19,481,000 | +21.6% | 609,985 | +12.1% | 0.04% | +12.1% |
Q3 2021 | $16,024,000 | -15.8% | 544,047 | -2.9% | 0.03% | -19.5% |
Q2 2021 | $19,037,000 | +11.6% | 560,263 | +7.1% | 0.04% | 0.0% |
Q1 2021 | $17,055,000 | +6.6% | 523,280 | +17.8% | 0.04% | -4.7% |
Q4 2020 | $16,004,000 | -9.3% | 444,286 | -1.8% | 0.04% | -18.9% |
Q3 2020 | $17,646,000 | +4.2% | 452,496 | -2.0% | 0.05% | -7.0% |
Q2 2020 | $16,933,000 | +125.4% | 461,676 | +0.1% | 0.06% | +83.9% |
Q1 2020 | $7,511,000 | – | 461,163 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |